Why Exact Sciences Stock Blasted Nearly 24% Higher Today

A strategic investor is reportedly in advanced talks to purchase the company.News of an apparently impending sale to a strategic investor sent shares of Exact Sciences (EXAS +23.68%) skyward on Wednesday. The cancer diagnostics specialist's shares closed the day nearly 24% higher in price as a result.Pinpointing the Exact reasonIn an article published that morning and updated in the afternoon, Bloomberg reported that pharmaceutical sector mainstay Abbott Laboratories appears to be on the brink of acquiring ...